Purchases and Sales Made in Q2 2023 in Xilio Therapeutics, Inc. (XLO)
This table provides information about the institutional ownership of Xilio Therapeutics, Inc. (XLO) during Q2 2023. The information is specifically focused on institutions that hold shares of Xilio Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 09, 2023
Q2 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
BUY
|
- |
11.9KNew |
$30.4K - $41.3K
|
11.9K
$10.5K
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
1.5K+ 7.98% |
$3.82K - $5.19K
|
20.3K
$17.9K
|
|
Aug 11, 2023
Q2 2023
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
901+ 5.33% |
$2.3K - $3.12K
|
17.8K
$15.7K
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
846+ 115.73% |
$2.16K - $2.93K
|
1.58K
$1.39K
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
3+ 3.85% |
$7.65 - $10.4
|
81
$71.3
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-69- 0.03% |
$176 - $239
|
227K
$200K
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-197- 4.29% |
$502 - $682
|
4.39K
$3.87K
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.79K- 3.52% |
$4.57K - $6.21K
|
49.2K
$43.3K
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.52K- 11.54% |
$8.98K - $12.2K
|
27K
$23.8K
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-3.85K- 23.0% |
$9.82K - $13.3K
|
12.9K
$11.3K
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-58.5K- 81.64% |
$149K - $202K
|
13.1K
$11.6K
|
|
Aug 14, 2023
Q2 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-122KClosed |
$311K - $422K
|
0
$0
|